Skip to content

Novanta NOVT Stock-Based Comp

Stock-Based Comp at other companies

Stryker logo
StrykerSYK
$87M+3.6%
Coherent logo
CoherentCOHR
$49.15M+20.0%
Intuitive Surgical logo
Intuitive SurgicalISRG
$209.5M+13.1%
Onto Innovation logo
Onto InnovationONTO
$7.01M+2.9%
Nordson logo
NordsonNDSN
$6.15M+28.3%
Globus Medical logo
Globus MedicalGMED
$12.62M-4.5%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's stock-based comp?
Novanta (NOVT) reported stock-based comp of $9.8M in Q1 2026.
How has Novanta's stock-based comp changed year-over-year?
Novanta's stock-based comp increased by 38.0% year-over-year, from $7.1M to $9.8M.
What is the long-term trend for Novanta's stock-based comp?
Over 4 years (2021 to 2025), Novanta's stock-based comp has grown at a 3.6% compound annual growth rate (CAGR), from $25.61M to $29.54M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.